D Amp M Pharma Peru Sac [cracked] Jun 2026

D&M Pharma Perú S.A.C. is a specialized pharmaceutical company based in Lima, Peru, that focuses on the distribution and marketing of high-quality therapeutic solutions. Established in 2006, the company acts as a strategic gateway for international pharmaceutical lines—most notably the Argentine Laboratorio Cassará —to reach the Peruvian healthcare market. Corporate Identity and Strategic Origins

Operating a dedicated risk-monitoring portal (farmacovigilancia@dympharmaperu.com) where patients and clinicians can report adverse events directly. Corporate Logistics and Information

The company’s compliance record is a key differentiator in an industry where counterfeit or mishandled drugs remain a concern in certain Latin American markets. By maintaining ISO and local health authority standards, D amp M Pharma Peru SAC assures partners of product integrity from port of entry to point of dispensation. d amp m pharma peru sac

: In the ocular health segment, the company offers tear substitutes and other specialized ophthalmological products.

The main product categories include:

For medical representatives, B2B procurement officers, and healthcare providers looking to coordinate with the company, the official administrative details for the Peruvian corporate entity include: D & M Pharma Peru S.A.C.

Solutions aimed at respiratory conditions. D&M Pharma Perú S

The corporate narrative of D&M Pharma (Desarrollos y Marketing Farmacéutico) began in Chile in May 2003, founded by a group of visionary pharmaceutical executives. A major structural milestone occurred in 2005 when the prestigious Argentine firm, , integrated into the ownership structure. Leveraging Cassará's vast manufacturing capabilities and regional prestige, D&M Pharma launched its international expansion.

This sector provides specialized clinical products designed to protect ocular health, offering localized treatments for dry eyes, allergies, and ocular micro-inflammation. Technical Rigor, Quality Assurance, and Pharmacovigilance : In the ocular health segment, the company